moderna vaccine news - Search News

mRNA, Moderna and Norovirus

Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US

US-based pharmaceutical company Moderna has dosed the first subject in the US in its Phase III Nova 301 clinical trial of its investigational norovirus vaccine, mRNA-1403. The Nova 301 trial aims to evaluate the vaccine's efficacy,

Business Insider · 2d

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been

Zacks.com on MSN · 21h

MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine

Moderna, Inc. MRNA announced the dosing of the first participant in the phase III Nova 301 study, which is evaluating its investigational mRNA norovirus vaccine candidate, mRNA-1403, in the United States.

Novavax, vaccine and COVID-19

CNET · 1d

Make Room, mRNA: What to Know About the Novavax COVID Vaccine

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season.

The Canadian Press on MSN · 16h

Canadian government not ordering Novavax's protein-based COVID-19 vaccine this year

The Public Health Agency of Canada says it is not providing Novavax's COVID-19 vaccine this respiratory virus season, citing low demand.

National Post · 15h

Canada not ordering Novavax protein-based COVID vaccine this year due to low demand

The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine,

CNET on MSN2d

Move Over, mRNA: What to Know About the Novavax COVID Vaccine

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

45m

Abbas Hussain Joins Moderna’s Board of Directors

Hussain brings more than 35 years of commercial leadership and operating experience in healthcare, most recently serving as CEO of Vifor Pharma ...

13d

COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

21h

Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...

FiercePharma1d

Moderna rebuked over second successive Spikevax marketing breach

Moderna has suffered its second PMCPA rebuke in quick succession. Days after ruling Moderna had brought discredit on the ...

Updated Covid-19 vaccine released for the first time this year

Last year only 23% of Americans got an updated COVID-19 vaccine, according to the CDC. They recommend those six months and ...

Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing ...

FiercePharma7d

Moderna blamed after kids offered $2,000 to participate in COVID-19 vaccine trial

The PCMPA has slammed Moderna over an unapproved WhatsApp message that offered children 1,500 pounds sterling ($2,000) to ...

11d

Moderna's updated COVID-19 vaccine is coming to Alberta, but Novavax shots are not

With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans ...

3don MSN

Moderna Inc (NASDAQ:MRNA): Jim Cramer Is Disappointed

We recently published a list of Jim Cramer’s Latest Portfolio: Top 9 Stocks to Buy and Sell. Since Moderna Inc (NASDAQ:MRNA) ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics